Prime Medicine Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

1.68

-0.06 (-3.45%)

At close: May 02, 2025, 3:59 PM

1.69

0.90%

After-hours: May 02, 2025, 05:48 PM EDT

Prime Medicine Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-195.88M	-198.13M	-121.82M	-165.37M	-3.41M	-2.53M
Depreciation & Amortization	6.13M	4.65M	2.22M	568K	43K	n/a
Stock-Based Compensation	26.07M	13.91M	6.46M	1.75M	391K	n/a
Other Working Capital	36.33M	-6.49M	-37.86M	29.99M	-86K	492K
Other Non-Cash Items	9.74M	11.79M	17.68M	98.42M	-4.6M	703K
Deferred Income Tax	n/a	-279K	-964K	-624K	1.87M	n/a
Change in Working Capital	31.08M	2.65M	-35.4M	31.18M	164K	492K
Operating Cash Flow	-122.86M	-165.41M	-131.83M	-34.08M	-5.54M	-1.33M
Capital Expenditures	-7.29M	-8.72M	-16.09M	-4.15M	-639K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-129.45M	-104.95M	-123.34M	-81.98M	n/a	n/a
Sales Maturities Of Investments	204.2M	132.56M	93M	13M	n/a	n/a
Other Investing Acitivies	1M	-170K	-665K	-496K	-423K	n/a
Investing Cash Flow	68.46M	18.71M	-47.1M	-73.63M	-1.06M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	25.74M	655K	-3.82M	-1.09M	-20K	9.98M
Financial Cash Flow	195.88M	655K	181.49M	269.28M	34.93M	9.98M
Net Cash Flow	141.47M	-146.05M	2.57M	161.57M	28.33M	8.65M
Free Cash Flow	-130.16M	-174.14M	-147.92M	-38.23M	-6.18M	-1.33M